Cargando…

A nomogram based on (18)F-fluorodeoxyglucose PET/CT and clinical features to predict epidermal growth factor receptor mutation status in patients with lung adenocarcinoma

BACKGROUND: Identifying epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma (LADC) is vital for treatment decision-making. This study aimed to establish a convenient and noninvasive nomogram prediction model based on (18)F-fluorodeoxyglucose positron emission tomography/computed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yue, Zhu, Hui, Chen, Congxia, Li, Xu, Liu, Fugeng, Yao, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622444/ https://www.ncbi.nlm.nih.gov/pubmed/36330175 http://dx.doi.org/10.21037/qims-22-248

Ejemplares similares

Combination of (18)F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Li, Shen, et al.
Publicado: (2022)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013)

(18)F-Fluorodeoxyglucose PET/CT in a Patient with Esophageal and Genital Leiomyomatosis
por: An, Young-Sil, et al.
Publicado: (2009)

Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT
por: Seshadri, Nagabhushan, et al.
Publicado: (2010)

False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma
por: Corbin, Haley, et al.
Publicado: (2021)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma
por: Yang, Bin, et al.
Publicado: (2020)

Association between histopathological subtype, (18)F-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in lung adenocarcinoma
por: QIANG, GUANGLIANG, et al.
Publicado: (2016)

F-18 Fluorodeoxyglucose PET/CT and Post Hoc PET/MRI in a Case of Primary Meningeal Melanomatosis
por: Lee, Hong Je, et al.
Publicado: (2013)

Central Pontine Myelinolysis and Localized Fluorodeoxyglucose Uptake Seen on (18)F-FDG PET/CT
por: Rønne, Frederik, et al.
Publicado: (2017)

Utility of (18)F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma
por: Jitani, Ankit Kumar, et al.
Publicado: (2021)

An Exceptional Cause of Increased (18)F-Fluorodeoxyglucose Uptake on PET/CT in a Thyroid Nodule
por: Manta, Ringo, et al.
Publicado: (2023)

(18)Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies
por: Bıçakçı, Nilüfer, et al.
Publicado: (2021)

(18)F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line EGFR-TKIs
por: Huang, Yu-Erh, et al.
Publicado: (2022)

CT, MRI, and (18)F-FDG PET/CT imaging features of seven cases of adult pancreatoblastoma
por: Wu, Mengnan, et al.
Publicado: (2022)

Correlations Study Between (18)F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma
por: Yang, Bin, et al.
Publicado: (2019)

Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis
por: Lee, Jeong Won, et al.
Publicado: (2020)

Relative clinical utility of simultaneous (18)F-fluorodeoxyglucose PET/MRI and PET/CT for preoperative cervical cancer diagnosis
por: Gong, Jing, et al.
Publicado: (2021)

Correlation between EGFR mutation status and F(18)‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2019)

Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT
por: Öztürk, Hakan
Publicado: (2015)

Radiomic signature of( 18)F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits
por: Jiang, Yuming, et al.
Publicado: (2018)

Efficacy of (18)F-fluorodeoxyglucose PET/CT for Detecting Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Lee, Dong Won, et al.
Publicado: (2018)

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma
por: Lim, Jun Hyeok, et al.
Publicado: (2020)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients
por: Sprinz, Clarice, et al.
Publicado: (2018)

Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)

Forced diuresis and dual-phase (18)F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
por: Harkirat, S, et al.
Publicado: (2010)

Paraneoplastic ocular sarcoidosis in the setting of recurrent rectal carcinoid tumor diagnosed by F(18)-fluorodeoxyglucose PET CT
por: Marlow, Elizabeth D., et al.
Publicado: (2020)

Prevalence of incidental thyroid malignancy on routine (18)F-fluorodeoxyglucose PET-CT in a large teaching hospital
por: Roddy, Shea, et al.
Publicado: (2020)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Ruptured epidermal cyst mimicking cutaneous melanoma on F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

The predictive value of [(18)F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Pulmonary Actinomycosis Mimicking Pulmonary Cancer on Fluorine-18 Fluorodeoxyglucose PET-CT
por: Tanaka, Shota, et al.
Publicado: (2020)

Relationship between Preoperative (18)F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer
por: Choi, Yun Jung, et al.
Publicado: (2016)

Clinical Utility of (18)Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography ((18)F-FDG PET/CT) in Multivisceral Transplant Patients
por: Ong, Shao Jin, et al.
Publicado: (2023)

(18)F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma
por: An, Shuxian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6u7hntpq2df841fie41bpgm9r2